Thomas Hughes

Dr. Thomas E.
Hughes is an Independent Director at Constant Therapeutics LLC, an Advisor at Atlas Venture Advisors, Inc., a Chairman at Totus Medicines, Inc., a President & Director at Anakuria Therapeutics, Inc., a strategic advisory boards at HotSpot Therapeutics, Inc. and a strategic advisory boards at Nimbus Therapeutics LLC.
He is on the Board of Directors at Deep Genomics, Inc. and Anakuria Therapeutics, Inc. Dr. Hughes was previously employed as a President, Chief Executive Officer & Director by Navitor Pharmaceuticals, Inc., an Independent Director by Miragen Therapeutics, Inc., a President, Chief Scientific Officer & Director by Zafgen, Inc., a VP & Head-Metabolic Diseases Therapeutic Area by Novartis Institutes for Biomedical Research, Inc., and a Strategic Advisory Board by Broadview Ventures, Inc. He also served on the board at miRagen Therapeutics, Inc. /Old/.
He received his undergraduate degree from Franklin & Marshall College, a graduate degree from Virginia Polytechnic Institute & State University and a doctorate degree from Tufts University.